Synthetic Lethal Targeting of PTEN-Deficient Cancer Cells Using Selective Disruption of Polynucleotide Kinase/Phosphatase
- 1 October 2013
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 12 (10) , 2135-2144
Abstract
A recent screen of 6,961 siRNAs to discover possible synthetic lethal partners of the DNA repair protein polynucleotide kinase/phosphatase (PNKP) led to the identification of the potent tumor suppressor phosphatase and tensin homolog deleted on chromosome 10 (PTEN). Here, we have confirmed the PNKP/PTEN synthetic lethal partnership in a variety of different cell lines including the PC3 prostate cancer cell line, which is naturally deficient in PTEN. We provide evidence that codepletion of PTEN and PNKP induces apoptosis. In HCT116 colon cancer cells, the loss of PTEN is accompanied by an increased background level of DNA double-strand breaks, which accumulate in the presence of an inhibitor of PNKP DNA 3′-phosphatase activity. Complementation of PC3 cells with several well-characterized mutated PTEN cDNAs indicated that the critical function of PTEN required to prevent toxicity induced by an inhibitor of PNKP is most likely associated with its cytoplasmic lipid phosphatase activity. Finally, we show that modest inhibition of PNKP in a PTEN knockout background enhances cellular radiosensitivity, suggesting that such a “synthetic sickness” approach involving the combination of PNKP inhibition with radiotherapy may be applicable to PTEN-deficient tumors. Mol Cancer Ther; 12(10); 2135–44. ©2013 AACR.Keywords
All Related Versions
This publication has 49 references indexed in Scilit:
- Tidying up loose ends: the role of polynucleotide kinase/phosphatase in DNA strand break repairTrends in Biochemical Sciences, 2011
- Harnessing synthetic lethal interactions in anticancer drug discoveryNature Reviews Drug Discovery, 2011
- PTEN Level in Tumor Suppression: How Much Is Too Little?Cancer Research, 2011
- BMI1-mediated histone ubiquitylation promotes DNA double-strand break repairJournal of Cell Biology, 2010
- DNA Polymerases as Potential Therapeutic Targets for Cancers Deficient in the DNA Mismatch Repair Proteins MSH2 or MLH1Cancer Cell, 2010
- Targeting the PI3K signaling pathway in cancerCurrent Opinion in Genetics & Development, 2010
- Mechanism of Action of an Imidopiperidine Inhibitor of Human Polynucleotide Kinase/PhosphataseJournal of Biological Chemistry, 2010
- Tumor Suppression by PTEN Requires the Activation of the PKR-eIF2α Phosphorylation PathwayScience Signaling, 2009
- Synthetic lethal targeting of PTEN mutant cells with PARP inhibitorsEMBO Molecular Medicine, 2009
- The Concept of Synthetic Lethality in the Context of Anticancer TherapyNature Reviews Cancer, 2005